Up-regulation of activating and inhibitory NKG2 receptors in allogeneic and autologous hematopoietic stem cell grafts-Reference-Cited by-同舟云学术

Up-regulation of activating and inhibitory NKG2 receptors in allogeneic and autologous hematopoietic stem cell grafts

Published:2015-09-11 Issue:1 Volume:34 Page:
ISSN:1756-9966
Container-title:Journal of Experimental & Clinical Cancer Research
language:en
Short-container-title:J Exp Clin Cancer Res

Author:

Picardi Alessandra,Mengarelli Andrea,Marino Mirella,Gallo Enzo,Benevolo Maria,Pescarmona Edoardo,Cocco Roberta,Fraioli Rocco,Tremante Elisa,Petti Maria Concetta,De Fabritiis Paolo,Giacomini Patrizio

Funder

Associazione Italiana Ricerca sul Cancro

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s13046-015-0213-y.pdf

Reference36 articles.

1. Leung W. Use of NK cell activity in cure by transplant. Br J Haematol. 2011;155(1):14–29. doi: 10.1111/j.1365-2141.2011.08823.x .

2. Murphy WJ, Parham P, Miller JS. NK cells-from bench to clinic. Biol Blood Marrow Transplant. 2012;18(1 Suppl):S2–7. doi: 10.1016/j.bbmt.2011.10.033 .

3. Babor F, Fischer JC, Uhrberg M. The role of KIR genes and ligands in leukemia surveillance. Front Immunol. 2013;4:27. doi: 10.3389/fimmu.2013.00027 .

4. Hsu KC, Keever-Taylor CA, Wilton A, Pinto C, Heller G, Arkun K, et al. Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes. Blood. 2005;105(12):4878–84. doi: 10.1182/blood-2004-12-4825 .

5. Venstrom JM, Zheng J, Noor N, Danis KE, Yeh AW, Cheung IY, et al. KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma. Clin Cancer Res. 2009;15(23):7330–4. doi: 10.1158/1078-0432.CCR-09-1720 .

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Activating NKG2C Receptor: Functional Characteristics and Current Strategies in Clinical Applications;Archivum Immunologiae et Therapiae Experimentalis;2023-03-10

2. The Interaction of HLA-C1/KIR2DL2/L3 Promoted KIR2DL2/L3 Single-Positive/NKG2C-Positive Natural Killer Cell Reconstitution, Raising the Incidence of aGVHD after Hematopoietic Stem Cell Transplantation;Frontiers in Immunology;2022-04-29

3. C-Type Lectin (C-Type Lectin Receptor);Glycobiology of Innate Immunology;2022

4. Anti-NKG2C/IL-15/anti-CD33 killer engager directs primary and iPSC-derived NKG2C+ NK cells to target myeloid leukemia;Molecular Therapy;2021-12

5. NKG2D Natural Killer Cell Receptor—A Short Description and Potential Clinical Applications;Cells;2021-06-07